13F HOLDINGS REPORT
Avoro Capital Advisors LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001104659-24-089335
Total Value
$7.51B
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP | UTHR | 2,858,888 | $910.7M | 12.13% |
| 2 | MADRIGAL PHARMACEUTICALS INC | MDGL | 2,055,555 | $575.9M | 7.67% |
| 3 | ASCENDIS PHARMA | ASND | 4,196,661 | $572.3M | 7.62% |
| 4 | ARGENX SE | ARGX | 1,238,467 | $532.6M | 7.09% |
| 5 | SAREPTA THERAPEUTICS INC | SRPT | 3,000,000 | $474.0M | 6.31% |
| 6 | KRYSTAL BIOTECH INC | KRYS | 2,433,000 | $446.8M | 5.95% |
| 7 | APELLIS PHARMACEUTICALS INC. | APLS | 11,111,111 | $426.2M | 5.68% |
| 8 | BIOMARIN PHARMACEUTICAL INC | BMRN | 4,557,416 | $375.2M | 5.00% |
| 9 | CEREVEL THERAPEUTICS HLDNG | 15678U128 | 7,539,547 | $308.3M | 4.11% |
| 10 | SPDR SERIES TRUST - S&P BIOTECH | 78464A870 | 3,035,000 | $281.4M | 3.75% |
| 11 | AMICUS THERAPEUTICS INC. | FOLD | 27,400,000 | $271.8M | 3.62% |
| 12 | AVIDITY BIOSCIENCES INC | 05370A108 | 6,505,000 | $265.7M | 3.54% |
| 13 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | 8,888,888 | $231.0M | 3.08% |
| 14 | XENON PHARMACEUTICALS INC | XENE | 5,666,666 | $220.9M | 2.94% |
| 15 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 3,000,000 | $205.5M | 2.74% |
| 16 | VERA THERAPEUTICS INC | VERA | 4,309,590 | $155.9M | 2.08% |
| 17 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 2,770,000 | $121.8M | 1.62% |
| 18 | KYMERA THERAPEUTICS INC | KYMR | 3,888,888 | $116.1M | 1.55% |
| 19 | ALNYLAM PHARMCEUTICALS INC. | ALNY | 400,000 | $97.2M | 1.29% |
| 20 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 11,700,000 | $93.8M | 1.25% |
| 21 | SOLENO THERAPEUTICS INC | SLNO | 2,091,666 | $85.3M | 1.14% |
| 22 | MERUS N V | N5749R100 | 1,355,000 | $80.2M | 1.07% |
| 23 | SYNDAX PHARMACEUTICALS INC | SNDX | 3,888,437 | $79.8M | 1.06% |
| 24 | BIOCRYST PHARMACEUTICALS INC | BCRX | 12,570,000 | $77.7M | 1.03% |
| 25 | KURA ONCOLOGY INC | KURA | 3,541,505 | $72.9M | 0.97% |
| 26 | OCULAR THERAPEUTIX INC | OCUL | 8,060,000 | $55.1M | 0.73% |
| 27 | MANNKIND CORP | MNKD | 8,759,524 | $45.7M | 0.61% |
| 28 | VAXCYTE INC | PCVX | 575,000 | $43.4M | 0.58% |
| 29 | SPYRE THERAPEUTICS INC | SYRE | 1,839,138 | $43.2M | 0.58% |
| 30 | AUTOLUS THERAPEUTICS PLC | AUTL | 12,345,678 | $43.0M | 0.57% |
| 31 | TAYSHA GENE THERAPIES INC | TSHA | 18,650,000 | $41.8M | 0.56% |
| 32 | ULTRAGENYX PHARMACEUTICAL INC | RARE | 830,000 | $34.1M | 0.45% |
| 33 | VERRICA PHARMACEUTICALS INC | VRCA | 3,999,999 | $29.2M | 0.39% |
| 34 | TOURMALINE BIO INC | 89157D105 | 2,222,222 | $28.6M | 0.38% |
| 35 | CG ONCOLOGY INC | CGON | 700,000 | $22.1M | 0.29% |
| 36 | MONTE ROSA THERAPEUTICS INC | GLUE | 4,535,000 | $17.0M | 0.23% |
| 37 | BICYCLE THERAPEUTICS PLC | BCYC | 700,000 | $14.2M | 0.19% |
| 38 | AADI BIOSCIENCES INC | WHWK | 2,849,402 | $4.2M | 0.06% |
| 39 | DYNE THERAPEUTICS INC. | DYN | 115,751 | $4.1M | 0.05% |
| 40 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 416,666 | $2.9M | 0.04% |
| 41 | NEUROGENE INC | NGNE | 22,029 | $801,635 | 0.01% |